Evidence map›Paper›PMID 23412359›Full record

ArticleTranscription

HIF proteins connect the RB-E2F factors to angiogenesis.

Walbert J Bakker, Bart G M W Weijts, Bart Westendorp, Alain de Bruin

Open access · hybridAbstract read
In one paragraph

Article in Transcription. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans.Clinical cancer research : an official journal of the American Association for Cancer Research · 2022
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. The role of E2F8 in the human placenta.Molecular medicine reports · 2019
    Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Walbert J BakkerDepartment of Pathobiology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
Bart G M W Weijts
Bart Westendorp
Alain de Bruin
University of Veterinary Medicine · HUUtrecht University · NL

Funding

Worldwide Cancer Research 09-0718
6 · The paper itself

Abstract

Recently, we showed that E2F7 and E2F8 (E2F7/8) are critical regulators of angiogenesis through transcriptional control of VEGFA in cooperation with HIF. (1) Here we investigate the existence of other novel putative angiogenic E2F7/8-HIF targets, and discuss the role of the RB-E2F pathway in regulating angiogenesis during embryonic and tumor development.

Indexed as

AnimalsBinding SitesE2F Transcription FactorsHumansHypoxia-Inducible Factor 1NeoplasmsNeovascularization, PathologicReceptors, Vascular Endothelial Growth FactorRepressor ProteinsVascular Endothelial Growth Factor AE2F Transcription FactorsHypoxia-Inducible Factor 1Receptors, Vascular Endothelial Growth FactorRepressor ProteinsVascular Endothelial Growth Factor AangiogenesiscancerE2FHIFhypoxiaRBVEGF

Identifiers

PMID23412359
PMCPMC3646055
OpenAlexW2033317978

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.